Search Within

Head and Neck Service

Formats
  1. Journal Article (417)
  2. Meeting Abstract (361)
  3. Book Section (21)
  4. Review (19)
  5. Editorial (7)
  6. Guidelines (7)
  7. Research Letter (6)
  8. Correspondence (5)
  9. Book Whole (1)
  10. Conference Paper (1)
  11. Miscellaneous (1)
Groups
  1. Solid Tumor Oncology Division (846)
  2. Department of Medicine (840)
  3. Surgery (365)
  4. Head and Neck Surgery (344)
  5. Radiation Oncology, Department of (315)
  6. Survivorship Research (313)

More Groups

People
  1. David Pfister (391)
  2. Eric Sherman (350)
  3. Nancy Lee (271)
  4. Alan Ho (247)
  5. Nadeem Riaz (164)
  6. Richard Wong (144)

More People

Years
  1. 2025 (24)
  2. 2024 (72)
  3. 2023 (55)
  4. 2022 (57)
  5. 2021 (58)
  6. 2020 (67)

More Years

Publications
  1. Journal of Clinical Oncology (208)
  2. International Journal of Radiation Oncology, Biology, Physics (140)
  3. Annals of Oncology (43)
  4. Cancer (33)
  5. Head & Neck (29)
  6. Journal of the National Comprehensive Cancer Network (28)

More Publications

Publishers
  1. American Society of Clinical Oncology (222)
  2. Elsevier Inc. (178)
  3. Oxford University Press (56)
  4. Wiley Blackwell (54)
  5. American Association for Cancer Research (46)
  6. John Wiley & Sons, Inc. (29)

More Publishers

Results (846)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and efficacy of BRAF inhibitor plixorafenib (FORE8394; PLX8394) in children and adults with recurrent, BRAF-altered primary central nervous system tumors (PCNST)
    Meeting Abstract

    de la Fuente, M.; Butowski, N. A.; Taylor, J.; Yaeger, R.; Tsai, F. Y. C.; Janku, F.; Allen, C. E.; Ammakkanavar, N.; Michelson, G.; Jiang, P.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Tumor Hypoxia on 18F-fluoromisonidazole positive emission tomography as a predictor of distant metastasis-free survival after chemoradiation for head and neck squamous cell carcinoma: A pooled analysis of clinical trials
    Meeting Abstract

    Gui, C.; Wray, R.; Schoder, H.; Grkovski, M.; Humm, J.; Wong, R. J.; Sherman, E.; Riaz, N.; Lee, N. Y.
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Cooperative genomic lesions in HRAS-mutant cancers predict resistance to farnesyltransferase inhibitors
    Journal Article

    Nigam, A.; Krishnamoorthy, G. P.; Chatila, W. K.; Berman, K.; Saqcena, M.; Walch, H.; Venkatramani, M.; Ho, A. L.; Schultz, N.; Fagin, J. A.; more...
    Oncogene (2024)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy and in combination with pembrolizumab, in patients with recurrent/metastatic HPV16+ head and neck squamous cell cancer (R/M HNSCC)
    Meeting Abstract

    Colevas, A. D.; Chung, C. H.; Adkins, D.; Rodriguez, C. P.; Park, J. C.; Gibson, M. K.; Sukari, A.; Worden, F. P.; Johnson, F. M.; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Comparative patient-reported tolerability (PRT): A multiplicity-controlled analysis of LIBRETTO-531, a randomized controlled trial (RCT) in medullary thyroid cancer (MTC)
    Meeting Abstract

    Brose, M. S.; Robinson, B.; Wirth, L. J.; Capdevila, J.; Wadsley, J.; Sherman, E. J.; Tahara, M.; Hoff, A.; Hu, M. I. N.; Gao, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results
    Meeting Abstract

    Ho, A. L.; Nabell, L.; Neupane, P. C.; Posner, M. R.; Yilmaz, E.; Niu, J.; Naqash, A. R.; Pearson, A. T.; Wong, S. J.; Nieva, J. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C
    Meeting Abstract

    Sun, L.; Fayette, J.; Salas, S.; Hong, D. S.; Adkins, D.; Dunn, L.; Ciardiello, F.; Cirauqui, B.; William, W. N. Jr; Saba, N. F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein-Barr virus-associated nasopharyngeal carcinoma
    Meeting Abstract

    Colevas, A. D.; Cohen, R. B.; Park, J. C.; Pfister, D. G.; Massarelli, E.; Li, Z.; Xing, B.; Dinavahi, R.; Mehta, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus-related oropharyngeal cancer
    Meeting Abstract

    Lee, N. Y.; Sherman, E. J.; Schòˆder, H.; Wray, R.; White, C.; Dunn, L.; Hung, T.; Pfister, D. G.; Ho, A. L.; McBride, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Prescribers of opioids for head and neck cancer (HNC) survivors
    Meeting Abstract

    Salz, T.; Meza, A. M.; Bradshaw, P. T.; Jinna, S.; Moryl, N.; Kriplani, A.; Tringale, K. R.; Flory, J.; Korenstein, D.; Lipitz-Snyderman, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save